Clinical Trials Browser

Phase EARLY_PHASE1 × Ovarian Neoplasms × Salpingo-oophorectomy × Clear all

NCT03382574 2022-06-14

Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy

Phase EARLY_PHASE1 Terminated

Ovarian Neoplasms